Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy

T Dung Nguyen1, P Christian Schulze1

  • 1Department of Internal Medicine I, University Hospital Jena, Jena, Germany.

Circulation Research
|April 13, 2023
PubMed

Insights

Chronic kidney disease (CKD) causes cardiovascular issues and a specific heart condition called uremic cardiomyopathy. Research suggests CKD heart metabolism shares similarities with heart failure, offering new therapeutic targets.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolism

Background:

  • Chronic kidney disease (CKD) elevates cardiovascular disease risk, including hypertension and coronary artery disease.
  • CKD induces cardiac structural remodeling (hypertrophy, fibrosis) and functional impairments, defining uremic cardiomyopathy.
  • Cardiac function is intrinsically linked to myocardial metabolism, with significant remodeling observed in heart failure.

Purpose of the Study:

  • To review cardiac metabolic remodeling in heart failure.
  • To extend this understanding to uremic cardiomyopathy in CKD patients.
  • To identify potential overlapping and distinct metabolic mechanisms between heart failure and uremic cardiomyopathy.

Main Methods:

  • Literature review of cardiac metabolism in heart failure.
  • Analysis of recent findings on metabolism in uremic cardiomyopathy.
  • Comparative assessment of metabolic remodeling in both conditions.

Main Results:

  • Significant metabolic remodeling occurs in the failing heart.
  • Emerging data suggest overlapping metabolic pathways in uremic cardiomyopathy and heart failure.
  • Specific differences in cardiac metabolism between these conditions are yet to be fully elucidated.

Conclusions:

  • Understanding similarities and differences in cardiac metabolism is crucial for uremic cardiomyopathy research.
  • Identifying shared mechanisms may reveal novel therapeutic targets for both heart failure and CKD-related cardiac dysfunction.
  • Further research into uremic heart metabolism is warranted to develop targeted therapies.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
28
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
433
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
20
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20